|
Volumn 10, Issue 4, 2002, Pages 6-7
|
Medications for postmenopausal osteoporosis prevention.
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALENDRONIC ACID;
ANTIESTROGEN;
CONJUGATED ESTROGEN;
DRUG DERIVATIVE;
ETIDRONIC ACID;
RALOXIFENE;
RISEDRONIC ACID;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
ARTICLE;
BONE DENSITY;
ESTROGEN THERAPY;
FEMALE;
HUMAN;
POSTMENOPAUSE OSTEOPOROSIS;
RISK FACTOR;
ALENDRONATE;
BONE DENSITY;
ESTROGEN ANTAGONISTS;
ESTROGEN REPLACEMENT THERAPY;
ESTROGENS, CONJUGATED (USP);
ETIDRONIC ACID;
FEMALE;
HUMANS;
OSTEOPOROSIS, POSTMENOPAUSAL;
RALOXIFENE;
RISK FACTORS;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
|
EID: 0036885118
PISSN: 1070910X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|